Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1516 participants.

Also called NCT00970489

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 1,516 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT00970489
Other papers using this trial's data
  • Fish Oil Supplementation Does Not Affect Cognitive Outcomes in Cardiac Surgery Patients in the Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial The Journal of nutrition, 2018-03-01 DOI, PubMed 29546292, PMC6454465 Not in the PMC Open Access subset.
  • Fish Oil and Perioperative Bleeding Circulation. Cardiovascular quality and outcomes, 2018-11 DOI, PubMed 30571332, PMC6376981 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial JAMA, 2012-11-21 DOI, PubMed 23128104, PMC3694745 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial Journal of the American Heart Association, 2013-10-21 DOI, PubMed 24145742, PMC3835252 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT00970489. Randomized; quadruple masking; primary purpose prevention. Start 2010-08 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2017-04-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation
Acronym
OPERA
Intervention (Drug)
Omega -3 fatty acids
Intervention (Drug)
Placebo
Lead sponsor
Brigham and Women's Hospital (class: other)
Collaborator
The OPERA Investigators (class: not stated)

Record details

Record id
cardio:ct-nct00970489
Content hash
728d4b0c052fa25d00e83eed5f39ba26207c65f619dc38078fdc51bf7630a7a7